Compare StocksABBV vs CHRW

AbbVie Inc. (ABBV) vs C.H. Robinson Worldwide, Inc. (CHRW)

ABBV
AbbVie Inc.
$206.23
VS
CHRW
C.H. Robinson Worldwide, Inc.
$174.81

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 71.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 83/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CHRW
  • C.H. Robinson Worldwide, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Each dollar of retained earnings has created $17.11 of market value — management is an exceptional capital allocator.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.0% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 87.0x is 39% above the historical average of 62.5x — the stock trades at a premium to its own history.
CHRW
  • Gross margin of 8.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Buybacks have been poorly timed — 2 out of 3 years involved repurchases at relatively expensive valuations.
  • Trailing P/E of 36.3x is 40% above the historical average of 25.8x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
ABBV
CHRW
Valuation
$18.34B
Free Cash Flow
$742.47M
5.03%
FCF Yield
3.58%
87.02
Trailing P/E
36.27
12.80
Forward P/E
24.42
Quality & Moat
24.09%
ROIC
20.06%
N/A
ROE
31.81%
71.62%
Gross Margin
8.55%
N/A
PEG Ratio
N/A
Balance Sheet Safety
N/A
Debt / Equity
0.76
N/A
Interest Coverage
N/A
2.16
Net Debt / EBITDA
1.41
3.36%
Dividend Yield
1.44%
ABBV: 6Ties: 1CHRW: 2
ABBVCHRW

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

CHRW

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CHRW
$17.11
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$490.2M
Δ Market Cap
+$8.39B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
694.9% Overvalued
Price is 694.9% above estimated fair value
Current Price: $206.23
Fair Value: $25.94
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CHRW
5.9% Margin of Safety
Price is 5.9% below estimated fair value
Current Price: $174.81
Fair Value: $185.81
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $206?

+30.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +9.8%

The market implies +30.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +9.8%, reflecting heavy growth investment.

CHRW

What growth rate is the market pricing in at $175?

+16.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.0%

The market implies +16.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
83/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CHRW
61/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CHRW
-2.79
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.4%Retail & Other 23.5%
No. of Institutional Holders5,086
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CHRW
Insiders 0.8%Institutions 103.0%
No. of Institutional Holders1,137
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CHRW
3
Buys (3M)
3
Buys (12M)
Total value (12M): $400,535
BOZEMAN DAVID P
Chief Executive Officer
$199,771
@ $163.35 · 2026-02-12
CASTAGNETTO MICHAEL DAMIEN
Officer
$100,000
@ $168.35 · 2026-02-12
LEE DAMON J.
Chief Financial Officer
$100,764
@ $162.52 · 2026-02-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
3
Sells (3M)
6
Sells (12M)
Total value (12M): $34.15M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CHRW
5
Sells (3M)
12
Sells (12M)
Total value (12M): $21.14M
FREEMAN ANGELA K.
Officer
$1.72M
@ $200.52 · 2026-02-09
SHORT MICHAEL JOHN
Officer
$1.28M
@ $201.30 · 2026-02-09
CASTAGNETTO MICHAEL DAMIEN
Officer
$553,276
@ $194.20 · 2026-02-02
SHORT MICHAEL JOHN
Officer
$215,250
@ $175.00 · 2026-01-15
SHORT MICHAEL JOHN
Officer
$386,965
@ $161.91 · 2025-12-31
RAJAN ARUN
Officer
$381,925
@ $152.77 · 2025-11-17
FREEMAN ANGELA K.
Officer
$7.47M
@ $149.71 · 2025-11-06
CASTAGNETTO MICHAEL DAMIEN
Officer
$6.87M
@ $151.70 · 2025-11-03
RAJAN ARUN
Officer
$304,350
@ $121.74 · 2025-08-15
FREEMAN ANGELA K.
Officer
$664,096
@ $116.24 · 2025-08-11
SHORT MICHAEL JOHN
Officer
$746,125
@ $117.24 · 2025-08-06
FREEMAN ANGELA K.
Officer
$555,322
@ $97.42 · 2025-05-14
FREEMAN ANGELA K.
Officer
$803,120
@ $100.39 · 2025-02-27
CASTAGNETTO MICHAEL DAMIEN
Officer
$499,594
@ $99.60 · 2025-02-18
SHORT MICHAEL JOHN
Officer
$1.22M
@ $99.58 · 2025-02-18
CASTAGNETTO MICHAEL DAMIEN
Officer
$210,942
@ $103.81 · 2024-12-31
CAMPBELL BEN G
Officer
$2.86M
@ $110.00 · 2024-12-11
SHORT MICHAEL JOHN
Officer
$1.14M
@ $109.87 · 2024-11-11
CAMPBELL BEN G
Officer
$283,855
@ $102.11 · 2024-08-27
FREEMAN ANGELA K.
Officer
$834,003
@ $99.44 · 2024-08-16
SHORT MICHAEL JOHN
Officer
$1.07M
@ $98.38 · 2024-08-09
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CHRW
FearGreed
😐Neutral(48/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
CHRW
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (48)
View ABBV Full AnalysisView CHRW Full Analysis
AbbVie Inc. (ABBV) vs C.H. Robinson Worldwide, Inc. (CHRW) Stock Comparison | SafetyMargin.io